99 related articles for article (PubMed ID: 3902026)
1. Induction of DNA strand breaks by RSU-1069, a nitroimidazole-aziridine radiosensitizer. Role of binding of both unreduced and radiation-reduced forms to DNA, in vitro.
Silver AR; O'Neill P; Jenkins TC
Biochem Pharmacol; 1985 Oct; 34(19):3537-42. PubMed ID: 3902026
[TBL] [Abstract][Full Text] [Related]
2. The phosphate-group of DNA as a potential target for RSU-1069, a nitroimidazole-aziridine radiosensitizer.
Silver AR; O'Neill P; Jenkins TC; McNeil SS
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1203-6. PubMed ID: 3755715
[TBL] [Abstract][Full Text] [Related]
3. Induction of DNA crosslinks in vitro upon reduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131.
O'Neill P; McNeil SS; Jenkins TC
Biochem Pharmacol; 1987 Jun; 36(11):1787-92. PubMed ID: 3579973
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the aziridine moiety of RSU-1069 with nucleotides and inorganic phosphate. Implications for alkylation of DNA.
Silver AR; O'Neill P
Biochem Pharmacol; 1986 Apr; 35(7):1107-12. PubMed ID: 3754447
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the repair and damage of DNA induced by parent and reduced RSU-1069, a 2-nitroimidazole-aziridine.
O'Neill P; Cunniffe SM
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):963-6. PubMed ID: 2649467
[TBL] [Abstract][Full Text] [Related]
6. Induction of DNA strand breaks by reduced nitroimidazoles. Implications for DNA base damage.
Silver AR; McNeil SS; O'Neill P; Jenkins TC; Ahmed I
Biochem Pharmacol; 1986 Nov; 35(22):3923-8. PubMed ID: 3778516
[TBL] [Abstract][Full Text] [Related]
7. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
Jenner TJ; O'Neill P; Crump PW; Fielden EM; Sapora O; Santodonato L
Biochem Pharmacol; 1991 Oct; 42(9):1705-10. PubMed ID: 1930296
[TBL] [Abstract][Full Text] [Related]
8. Comparative DNA damage induced by nitroimidazole-aziridine drugs: 1. Effects of methyl substitution on drug action.
Dale LD; Tocher JH; Edwards DI
Anticancer Drug Des; 1988 Dec; 3(3):169-75. PubMed ID: 3207464
[TBL] [Abstract][Full Text] [Related]
9. Photosensitive interaction of RSU 1069 with DNA.
Edwards DI; Knox RJ; Skolimowski IM; Zahoor A; Knight RC
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1319-22. PubMed ID: 6547937
[TBL] [Abstract][Full Text] [Related]
10. Interaction of RSU 1069 and 1137 with DNA in vitro. Biological implications and mechanistic aspects.
Lafleur MV; Westmijze EJ; Visser OJ; Wagenaar N; Soetekouw R; Loman H; Retèl J
Biochem Pharmacol; 1991 Jun; 41(11):1649-55. PubMed ID: 1828345
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of DNA damage in mammalian cells upon bioreduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131.
Jenner TJ; Sapora O; O'Neill P; Fielden EM
Biochem Pharmacol; 1988 Oct; 37(20):3837-42. PubMed ID: 3190731
[TBL] [Abstract][Full Text] [Related]
12. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
Hill RP; Gulyas S; Whitmore GF
Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
[TBL] [Abstract][Full Text] [Related]
13. The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
Stratford IJ; Walling JM; Silver AR
Br J Cancer; 1986 Mar; 53(3):339-44. PubMed ID: 3754453
[TBL] [Abstract][Full Text] [Related]
14. Induction of mutations in V79-4 mammalian cells under hypoxic and aerobic conditions by the cytotoxic 2-nitroimidazole-aziridines, RSU-1069 and RSU-1131. The influence of cellular glutathione.
Sapora O; Paone A; Maggi A; Jenner TJ; O'Neill P
Biochem Pharmacol; 1992 Oct; 44(7):1341-7. PubMed ID: 1417957
[TBL] [Abstract][Full Text] [Related]
15. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
Cole S; Stratford IJ; Adams GE; Fielden EM; Jenkins TC
Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of some bioreducible 2-nitroimidazoles: comparison of in vitro cytotoxicity and ability to induce DNA strand breakage.
O'Neill P; Jenkins TC; Stratford IJ; Silver AR; Ahmed I; McNeil SS; Fielden EM; Adams GE
Anticancer Drug Des; 1987 Apr; 1(4):271-80. PubMed ID: 3450299
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and metabolism of the mixed-function hypoxic cell sensitizer prototype RSU 1069 in mice.
Walton MI; Workman P
Cancer Chemother Pharmacol; 1988; 22(4):275-81. PubMed ID: 3168141
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the techniques of alkaline filter elution and alkaline sucrose sedimentation used to assess DNA damage induced by 2-nitroimidazoles.
Crump PW; Fielden EM; Jenner TJ; O'Neill P
Biochem Pharmacol; 1990 Aug; 40(3):621-7. PubMed ID: 2383289
[TBL] [Abstract][Full Text] [Related]
19. RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions.
Stratford IJ; O'Neill P; Sheldon PW; Silver AR; Walling JM; Adams GE
Biochem Pharmacol; 1986 Jan; 35(1):105-9. PubMed ID: 3753579
[No Abstract] [Full Text] [Related]
20. Influence of nitrogen, oxygen, and nitroimidazole radiosensitizers on DNA damage induced by ionizing radiation.
Buchko GW; Weinfeld M
Biochemistry; 1993 Mar; 32(9):2186-93. PubMed ID: 8443160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
